title: Do randomised clinical trials influence practice?   The example of cerebral vein and dural sinus thrombosis.
authors.forename: José M
authors.initials: JM
authors.lastname: Ferro
authors.forename: Gabriela C
authors.initials: GC
authors.lastname: Lopes
authors.forename: Maria José
authors.initials: MJ
authors.lastname: Rosas
authors.forename: José M Bravo
authors.initials: JM
authors.lastname: Marques
authors.forename: José B
authors.initials: JB
authors.lastname: Costafor
mesh_terms: D000046:Academic Medical Centers / Q000706:statistics & numerical data; D002985:Clinical Protocols / Q000592:standards*; D004305:Dose-Response Relationship, Drug; D004502:Education, Medical, Continuing / Q000639:trends; D005104:Expert Testimony / Q000639:trends; D006493:Heparin / Q000008:administration & dosage*; D006801:Humans; D007275:Injections, Intravenous / Q000639:trends; D007279:Injections, Subcutaneous / Q000639:trends; D016032:Randomized Controlled Trials as Topic / Q000639:trends*; D012851:Sinus Thrombosis, Intracranial / Q000188:drug therapy*; D020246:Venous Thrombosis / Q000188:drug therapy*
chemical_list: D006493:Heparin